At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.
Latest News
Workforce Solutions
Three experts discussed novel and practical strategies and resources that rheumatology clinics can use to improve the referral process, screening times and patients access to care.
Advances in Giant Cell Arteritis
Dr. Philip Seo highlights the latest research into the assessment and treatment of giant cell arteritis presented during ACR Convergence 2025.
ACR Releases New Guideline for Management of SLE at ACR 2025
Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.
Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation
At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.
ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation
Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.
New Rheumatoid Arthritis Risk Stratification Criteria Released
New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.
Rheuminations: Address Ableism, Improve Care for All Patients
Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?
President’s Corner: Dr. Langford’s Reflections on the ACR’s 2025
Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s parting thoughts.
